Haifa, Israel

Lilach Avigdor

This inventor holds 11 USPTO granted patents and 29 published patent applications and 8 EPO patents. Top assignee: Novocure Gmbh. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lilach Avigdor. Retrieved from https://idiyas.com/inventor/lilach-avigdor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.8

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Lilach Avigdor: Innovator in Tumor Treatment Technologies

Introduction

Lilach Avigdor is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of medical technology, particularly in the treatment of tumors and diseases through innovative methods. With a total of 11 patents to her name, her work is paving the way for advancements in cancer treatment.

Latest Patents

Among her latest patents is a groundbreaking method for adjusting tumor treating fields simulation and treatment using molecular imaging. This computer-implemented method involves determining the optimal placement of transducers on a subject's body for applying tumor treating fields. The process includes analyzing image data to identify locations for transducer arrays, detecting target molecule concentrations, and recommending adjustments for improved treatment efficacy. Another notable patent focuses on methods of treating diseases by skewing macrophage phenotype with alternating electric fields. This innovative approach applies alternating electric fields to tissues, followed by administering treatments for various diseases, including kidney, heart, brain, and bone conditions.

Career Highlights

Lilach Avigdor is currently associated with Novocure GmbH, a company dedicated to developing innovative cancer therapies. Her work at Novocure highlights her commitment to advancing medical technology and improving patient outcomes.

Collaborations

Throughout her career, Lilach has collaborated with talented individuals, including Tali Voloshin-Sela and Reuven Ruby Shamir. These collaborations have further enriched her research and development efforts in the medical field.

Conclusion

Lilach Avigdor's contributions to tumor treatment technologies exemplify her dedication to innovation in medicine. Her patents and work at Novocure GmbH are significant steps toward improving treatment options for patients facing serious health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…